Comparison between biosimilar filgrastim vs other G-CSF formulations (originator filgrastim, peg-filgrastim and lenograstim) after autologous stem cell transplantation: a retrospective survey from the Rome Transplant Network
statistically significant difference among the four patient cohorts. We analyzed the time of hematologic recovery after stem cell infusion (defined as an absolute neutrophilis count upper than ... platelet transfusions…

